In a systematic review evaluating the efficacy of vaccines in patients using immunosuppressant therapy, it was noted that the use of TNF-α antagonists in combination with methotrexate was associated with a reduction of immunogenicity of influenza and pneumococcal vaccines [8, 29]. The gene discussed is TNF; the disease is influenza.